NPS

Call for Papers: New Drug and other Behavioural Trends During Social-Distancing for the COVID-19 Pandemic

This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our lifestyles might lead to the consumption of new emerging drugs and other risky behaviours. Potential Research Topic include, but are not limited to: Use, effects, markets of Novel Psychoactive Substances (NPS) and Image and Performance Enhancing Drugs (IPED). Use/abuse of anti-anxiety/sedative drugs, both

Opportunity to Publish a Scientific Article on New Psychoactive Substances!

UNODC is proud to be the co-editor of Special Issue “New Drug and other Behavioural Trends During Social-Distancing for the COVID-19 Pandemic” of the Journal “Emerging Trends in Drugs, Addictions, and Health” and cordially invites you to submit abstracts for consideration. You will find all information regarding this new Special Issue on this link: https://www.journals.elsevier.com/emerging-trends-in-drugs-addictions-and-health/call-for-papers/new-drug, as well as in the attached flyer. The important thing to note is that everything will be open access and

HIV/HCV prevalence and risk behavior among NPS users are a growing public health burden

On April 27, 2021, UNODC Regional Office for Central Asia held a training seminar for specialists of the republican and regional levels responsible for drug dependence treatment and HIV prevention services in the Republic of Uzbekistan. The main goal of the national training was to increase the capacity of government and non-government organizations that implement HIV and HCV prevention programs to provide effective evidence-based services for people who use new psychoactive substances (NPS) and stimulants

UNODC and partners discuss situation with New Psychoactive Substances in Kyrgyzstan

New psychoactive substances (NPS) are spreading at an unprecedented rate and are becoming a serious health threat and a real problem in drug policy in Central Asian countries. Little is known about the negative impact of NPS on human health and the harm they cause to society, and this significantly complicates prevention and treatment. To effectively counter this new problem, it is necessary to ensure constant monitoring of the drug situation, exchange of information and

EMCDDA Technical Report on New Psychoactive Substance

Published by
EMCDDA

The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid agonist that has recently emerged on the drug market in Europe, in order to support the risk assessment of the substance which has been requested by the European Commission.

Deaths Due to New Psychoactive Stimulants

Sydney, Australia,

This seminar will cover recent research on all deaths due to new psychoactive stimulants in Australia.

Seminar Summary:

This presentation will address mortality due to new psychoactive stimulants and hallucinogens. These cover a wide range of “designer drugs” that have risen to prominence in the 21st century and become a source of clinical concern. They include drugs such as synthetic cathinones and NBOMe.

Five-Year Global Plan of Action to Combat Emerging Synthetic Drug Threats

Published by
Bureau of International Narcotics and Law Enforcement Affairs (INL), U.S. Department of State
Publication Date

To deter and disrupt production and trafficking of illicit synthetic drugs into the United States, the Department of State has developed a new strategy that will attack this new business model of illicit international drug supply chains at all points to increase the cost, risk, and difficulties associated with producing, trafficking, and misusing these drugs.

Multilevel Population-Based Cross-Sectional Study Examining School Substance-Misuse Policy and the Use of Cannabis, Mephedrone and Novel Psychoactive Substances

Citation
Midgley LS, Murphy S, Moore G, et al Multilevel population-based cross-sectional study examining school substance-misuse policy and the use of cannabis, mephedrone and novel psychoactive substances among students aged 11–16 years in schools in Wales BMJ Open 2018;8:e020737. doi: 10.1136/bmjopen-2017-020737
Publication Date

Abstract

Objectives: To examine whether young peoples’ risk of cannabis, mephedrone and novel psychoactive substances (NPS) use is associated with school substance-misuse policy.

Design: A cross-sectional survey of secondary school students combined with a School Environment Questionnaire and independently coded school substance-misuse policies (2015/6).